Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cebranopadol in Moderate to Severe Acute Pain
NCT07845071Phase 3Recruiting
- Start
- Sep 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
A Phase 3 trial of cebranopadol in acute pain. Started Sep 2026; status: recruiting.
02
Drugs
cebranopadol
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT07845071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07845071.